路易体痴呆的诊断:123I-IMP与123I-MIBG闪烁显像能否提供新的核心特征?
本研究纳入332例疑似路易体痴呆(DLB)患者,评估123I-MIBG心肌闪烁显像与123I-IMP脑灌注SPECT能否为DLB诊断提供新的核心特征。结果显示仅早期H/M比值在多因素分析中差异显著,AUC为0.918,以早期H/M比值<2.0为阈值诊断很可能DLB的敏感度82.4%、特异度96.3%、准确率92.5%。作者认为早期H/M比值可作为DLB核心临床特征的可靠诊断指标。
要点
- 123I-MIBG心肌闪烁显像早期H/M比值<2.0诊断很可能DLB的敏感度82.4%、特异度96.3%、准确率92.5%。
- 早期H/M比值诊断很可能DLB的AUC为0.918,高于波动性认知、视幻觉和帕金森综合征。
- 123I-IMP脑灌注SPECT指标在多因素分析中未显示显著差异。
核心结论
- 123I-MIBG心肌闪烁显像获得的早期H/M比值可作为DLB核心临床特征的可靠诊断指标,可用于DLB的早期诊断和治疗。
研究设计与样本
- 纳入332例疑似DLB患者,均行123I-MIBG心肌闪烁显像和123I-IMP脑灌注SPECT;最终临床诊断很可能DLB 92例(男40例、女52例,平均年龄77.4±6.4岁,范围56-89岁),无DLB 240例(男98例、女142例,平均年龄75.5±9.0岁,范围70-87岁)。
诊断标准与关键数值
- 采用的核心临床特征为波动性认知、视幻觉和帕金森综合征;核医学评价指标包括123I-IMP闪烁显像后扣带回和楔前叶脑血流严重度评分及枕叶血流减低,以及123I-MIBG的早期和延迟心纵隔(H/M)比值和洗脱率。
临床应用与阅片要点
- 123I-MIBG心肌闪烁显像早期H/M比值<2.0诊断很可能DLB的敏感度82.4%、特异度96.3%、准确率92.5%,AUC为0.918;波动性认知、视幻觉和帕金森综合征的AUC分别为0.693、0.760和0.611。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Since the clinical symptoms of different types of dementia frequently overlap, especially in the earlier stages at onset, it is difficult to distinguish dementia with Lewy bodies (DLB) from other neurodegenerative dementias based on their clinical manifestations alone. Nuclear medicine imaging has been reported as a high-value index for the objective evaluation and diagnosis of DLB. The aim of this study was to evaluate whether nuclear medicine imaging findings may yield core features to be added to the diagnosis of DLB.
METHODS: We enrolled 332 patients with suspected DLB. All were evaluated by both 123I-metaiodobenzylguanidine (123I-MIBG) myocardial scintigraphy and 123I-labelled N-isopropyl-p-iodoamphetamine (123I-IMP). brain perfusion single-photon emission CT. The final clinical diagnosis indicated probable DLB in 92 patients (40 males, 52 females; mean age ± standard deviation, 77.4 ± 6.4 years; range, 56-89 years); 240 patients (98 males, 142 females; mean age, 75.5 ± 9.0 years; range, 70-87 years) were recorded as being without DLB. The accepted core features used for clinical evaluations were fluctuating cognition, visual hallucinations and Parkinsonism. The nuclear medicine evaluation indices were the severity score of cerebral blood flow on 123I-IMP scintigraphs of the posterior cingulate and praecuneus and a reduction in the blood flow in the occipital lobe. For 123I-MIBG evaluation, we recorded the early and delayed heart-to-mediastinum (H/M) ratios and the washout rate.
RESULTS: Univariate and multivariate analyses of fluctuating cognition, visual hallucinations, Parkinsonism and early H/M ratio in patients with probable and without DLB revealed significant differences. Parameters based on 123I-IMP studies did not show any significant differences by multivariate analysis. The area under the curve for the early H/M ratio was 0.918; for fluctuating cognition, visual hallucinations and Parkinsonism, it was 0.693, 0.760 and 0.611, respectively, by receiver-operating characteristic analysis. The early H/M ratio of <2.0 on 123I-MIBG scintigraphs was of the highest diagnostic accuracy. The sensitivity, specificity and accuracy for the diagnosis of probable DLB were 82.4%, 96.3% and 92.5%, respectively.
CONCLUSION: The early H/M ratio obtained by 123I-MIBG myocardial scintigraphy can serve as a reliable diagnostic index for the core clinical features of DLB. It can be used for the early diagnosis and treatment of DLB. Advances in knowledge: 123I-MIBG myocardial scintigraphy performed at the initial clinical examination can facilitate the early identification or exclusion of DLB and the early H/M ratio may be a diagnostic biomarker for DLB.
引用
- Sakamoto F, Shiraishi S, Tsuda N, et al. Diagnosis of dementia with Lewy bodies: can 123I-IMP and 123I-MIBG scintigraphy yield new core features? Br J Radiol. 2016. PMID: 27897064. doi:10.1259/bjr.20160156
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。